Studies have demonstrated that miR-21 plays an oncogene function in breast cancer by targeting tumor suppressor genes which include programmed cell death 4 (PDCD4), tropomyosin 1 (TPM1), and phosphatase and tensin homolog (PTEN) (68). This evidence concerns the gene PTEN and breast cancer.